*001128545
*00520230331051000.0
*007cr
*007ta
*008140728s1993    no#           000 0 eng
*00901632cam a2200373 c 4500
*015  $a9306551$2nbf
*019  $bl
*035  $a(EXLNZ-47BIBSYS_NETWORK)999403183694702201
*035  $a(NO-LaBS)14625104(bibid)
*035  $a(NO-TrBIB)101220391
*035  $a(NO-TrBIB)940318369
*035  $a940318369-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQU 95
*08274$a615.58$qNO-OsNB$24/nor
*24500$aCosts and effects on longevity of lipid lowering drugs$cErik Thorvik ... [et al.]
*260  $aOslo$bNational Institute of Public Health, Department of Health and Society, Unit for Health Services Research$c1993
*300  $a131 s.$bdiagr.
*4901 $aResearch report / National Institute of Public Health, Department of Health and Society, Unit for Health Services Research$vno. F 1/1993
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2008-01-08
*650 2$aAnticholesteremic Agents$_34469400
*650 2$aCost-benefit analysis$_25067100
*650 2$aDrug Utilization$_28118300
*650 2$aLongevity$_14575500
*653  $akolesterolreduksjon$akolestrolsenkende$alegemidler$amedisinterapi$akolesterolsenkende$_34469500
*7001 $aThorvik, Erik$0(NO-TrBIB)90403761$emedarb.$_34469600
*830 0$aForskningsrapport (Statens institutt for folkehelse. Avdeling for samfunnsmedisin. Seksjon for helsetjenesteforskning : trykt utg.)$x0803-9925$vno. F 1/1993$w999217770604702201$_34469700
*85641$3Fulltekst$uhttps://urn.nb.no/URN:NBN:no-nb_digibok_2008010804013$yNettbiblioteket$zDigital representasjon
*901  $a90
*913  $aNorbok$bNB
*999  $aoai:nb.bibsys.no:999403183694702202$b2021-11-14T19:50:44Z$z999403183694702202
^